3′-azido-3′-deoxy-5′-o-isonicotinoylthymidine: A novel antiretroviral analog of zidovudine. III. Solubility studies

Nucleosides, Nucleotides and Nucleic Acids

Volumn 25, Issue 2, 2006, Pages 191-202

  Teijeiro, Silvina A ^a   Briñón, Margarita C ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Cosolvency; Log linear and nonlinear solubilization models; Water solubility

Indexed keywords

3' AZIDO 3' DEOXY 5' O ISONICOTINOYLTHYMIDINE; ALCOHOL; ANTIRETROVIRUS AGENT; ISONICOTINIC ACID METHYL ESTER; NICOTINIC ACID DERIVATIVE; OCTANOL; PYRIDINE; SOLVENT; UNCLASSIFIED DRUG; WATER; ZIDOVUDINE DERIVATIVE; 3'-AZIDO-3'-DEOXY-5'-O-ISONICOTINOYLTHYMIDINE; DRUG DERIVATIVE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DETERMINATION; DRUG SOLUBILITY; NONLINEAR SYSTEM; PH; PREDICTION; CHEMISTRY; SOLUBILITY;

ANTI-RETROVIRAL AGENTS; HYDROGEN-ION CONCENTRATION; SOLUBILITY; ZIDOVUDINE;

EID: 31644436823     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770500446964     Document Type: Article

References (30)

1. Yalkowsky, S.H.; Valvani, S.C. Solubility and partitioning I: Solubility of nonelectrolytes in water. J. Pharm. Sci. 1980, 69(8), 912-922.
2. Martin, A. (Ed). Solubility and Distribution Phenomena. In: Physical Pharmacy. Solubility and Distribution Phenomena, 4th ed., Williams & Wilkins, Baltimore, 1993, Ch. 10, pp. 212-250.
3. Wells, J.I. Pharmaceutical Preformulation. The Physicochemical Properties of Drug Substances. Ellis Horwood, New York, 1993, 21-84.
4. Yalkowsky, S.H.; Roseman, T.J. Solubilization of Drugs by cosolvents. Yalkowsky, S.H. (Ed.); In: Techniques of Solubilization of Drugs. Dekker, New York, 1981, Ch. 3, pp. 91-134.
5. a) Rubino, J.T.; Blanchard, J.; Yalkowsky, S.H. Solubilization by cosolvents II: Phenytoin in binary and ternary solvents. J. Parenteral Sci and Techn. 1984, 38(6), 215-221.
6. b) Rubino, J.T.; Obeng, E.K. Influence of solute structure on deviations from the log-linear solubility equation in propylene glycol:water mixtures. J. Pharm. Sci. 1991, 80, 479-483.
7. Venkatesh, S. Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid. Pharm. Res. 1996, 13, 1453-1459.
8. Granero, G.; Bertorello, M.M. de; Briñón, M.C. Solubility profiles of isoxazolyl-naphthoquinone derivatives. Int. J. Pharm. 1999, 190, 41-47.
9. Motura, M.I.; Moroni, G.N.; Teijeiro, S.A.; Salomón, H.; Briñón, M.C. 3′-Azido-3′-deoxy-5′-O- isonicotinoylthymidine, a new prodrug of zidovudine. Synthesis, solid state characterization and and HIV-1 activity. Nucleos. Nucleot. Nucleic Acids 2002, 21(3), 217-230.
10. Turk, G.; Moroni, G.N.; Pampuro, S.; Briñón, M.C.; Salomón, H. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation with their chemical structure. Int. J. Antimicrob. Agents. 2002, 20(4), 282-288.
11. Teijeiro, S.A.; Moroni, G.N.; Motura, M.I.; Briñón, M.C. Lipophilic character of pyrimidinic nucleoside derivatives. Correlation between shake flask, chromatographic (RP-TLC and RP-HPLC) and theoretical methods. J. Liq. Chrom. & Rel. Technol. 2000, 23(6), 855-872.
12. Teijeiro, S.A.; Raviolo, M.A; Motura, M.I.; Briñón, M.C. 3′-Azido-3′-deoxy-5′-O-isonicotinoylthymidine, a novel antiretroviral analog of zidovudine. II. Stability in aqueous media and experimental and theoretical ionization constants. Nucleos. Nucleot. Nucleic Acids 2003, 22(9), 1789-1803.
13. Quevedo, M.A; Moroni, G.N.; Briñón, M.C. Human serum albumin binding of novel antiretroviral nucleoside derivatives of AZT. Biochem. Biophys. Res. Comm. 2001, 288(4), 954-960.
14. Quevedo, M.A.; Teijeiro, S.A.; Briñón, M.C. Plasma stability of a novel antiretroviral derivative studied by solid phase extraction and HPLC. J. Pharm. Biomed. Anal. B. 2004. Submitted for publication.
15. Higuchi, T.; Shih, F.L.; Kimura, J.H. Solubility determination of barely aqueous-soluble organic solids. J. Pharm. Sci. 1979, 68, 1267-1272.
16. a) Seedher, N; Bhatia, S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS Pharm. Sci. Tech. 2003, 4(3), E:33.
17. b) Rekker, R.F; Mannhold, R.; Bijloo, G.; de Vries, G; Dross, K. The lipophilic behaviour of organic compounds: 2. The development of an aliphatic hydrocarbon/water fragmental system via interconnection with octanol/water partitioning data. Quant. Struct.-Act. Relat. 1998, 17, 537-548.
18. c) Leo, A.J. Database of CLOGP for Windows, V 1.0.0, 1995.
19. d) Hansch, C.; Leo, A.J.; Hoekman, D. Exploring QSAR. Hydrophobic, Electronic, and Steric constants. ACS Professional Reference Book, Washington, 1995.
20. Perrin, D.D. Data from SRC PhysProp Database. www.chemfinder.com; Accessed October 8, 2005.
21. Li, A.; Yalkowsky, S.H. Solubility of organic solutes in ethanol/water mixtures. J. Pharm. Sci. 1994, 83, 1735-1740.
22. Li, P; Tabibi, E; Yalkowsky, S.H. Solubilization of ionized and un-ionized flavopiridol by etanol and polysorbate. J. Pharm. Sci. 20. 1999, 88(5), 507-509.
23. Millard, J.W; Alvarez-Nuñez, F.A; Yalkowsky, S.H. Solubilization by cosolvents establishing useful constants for the log-linear model. Int. J. Pharm. 2002, 245, 153-166.
24. Banerjee, S.; Yalkowsky, S.H. Cosolvent-induced solubilization of hydrophobic compounds into water. Anal. Chem. 1988, 60, 2153-2155.
25. Machatha, S.G.; Bustamante, P.; Yalkowsky, S.H. Deviation from linearity of drug solubility in etanol/water mixtures. Int. J. Pharm. 2004, 283, 83-88.
26. Paruta, A.N.; Sciarrone, B.J.; Lordi, N.G. Solubility of salicylic acid as a function of dielectric constant. J. Pharm. Sci. 1964, 53, 1349-1353.
27. Krishna, G.; Hodnick, W.F.; Lang, W.; Lin, X.; Karra, S.; Mao, J.; Almassian, B. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP 40101M. AAPS Pharm. Sci. Tech. 2001, 2(3), E:14.
28. Powell, M.; Nguyen, T.; Baloian, L. Compendium of excipients for parenteral formulations. PDA J. Pharm. Sci. Technol. 1998, 52, 238-311.
29. Mottu, F.; Laurent, A.; Rufenacht, D.; Doelker, E. Organic solvents for pharmaceutical parenterals and embolic liquids: A review of toxicity data. PDA J. Pharm. Sci. Technol. 2000, 54, 456-469.
30. Elving, P.; Markowitz, J.; Rosenthal, I. Preparation of buffer systems of constant ionic strength. Anal. Chem. 1956, 28, 1179-1180.